Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus
PLOS One · 2025
DOI: 10.1371/journal.pone.0333077 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Gad Murenzi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Einstein-Rwanda Research and Capacity Building Program, Research for Development and Rwanda Military Referral and Teaching Hospital, Kigali, Rwanda. Hauptthemen laut MEDLINE: HIV Infections, Papillomavirus Infections, Uterine Cervical Neoplasms, Papillomaviridae. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: National Cancer Institute, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Introduction
There are few data on the prevalence of cervical high-risk human papillomavirus (hrHPV), the necessary cause of cervical cancer, and its determinants among Rwandan women living with human immunodeficiency virus (HIV). We therefore aimed to assess the determinants of hrHPV positivity among Rwandan women living with HIV (WLWH).
Methods
We conducted a cervical cancer screening study of ~5,000 WLWH aged 30–54 years and living in Kigali, Rwanda, but originally from all provinces in the country, from 2016–2018. Women were tested for hrHPV by the Xpert assay (Cepheid, Sunnyvale, CA, USA). A nurse-administered questionnaire collected data on demographics and HPV/cervical cancer risk factors. Women without evidence of cervical precancer and cancer were included in the analysis.
Results
Women included in this analysis (N = 4,880) had a mean age of 40 years, > 98% were on antiretroviral therapy, and 61% had a CD4 count of ≥500 cells/µL. High-risk HPV prevalence was 25.5% [95% confidence interval (CI)=24.3%−26.8%] and the prevalence decreased with older ages and higher CD4 counts (p trend
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Einstein-Rwanda Research and Capacity Building Program, Research for Development and Rwanda Military Referral and Teaching Hospital, Kigali, Rwanda.
- National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
- Rwanda Military Referral and Teaching Hospital, Kigali, Rwanda.
- King Faisal Hospital, Kigali, Rwanda.
- Albert Einstein College of Medicine, Bronx, New York, United States of America.
- Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
ORCID-Profile: Gad Murenzi, Leon Mutesa
Förderung
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Murenzi, G., Kanyabwisha, F., Demarco, M., Muhoza, B., Hansen, K., Mivumbi, J. P., Murangwa, A., Rurangwa, T., Zawadi, T. M., Kubwimana, G., Gage, J. C., Hébert, T., Adedimeji, A., Nyirazinyoye, L., Yotebieng, M., Mutesa, L., Anastos, K., & Castle, P. E. (2025). Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus. PLOS One. https://doi.org/10.1371/journal.pone.0333077
Vancouver
Murenzi G, Kanyabwisha F, Demarco M, Muhoza B, Hansen K, Mivumbi JP, et al. Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus. PLOS One. 2025. doi:10.1371/journal.pone.0333077
BibTeX
@article{Murenzi2025,
author = {Murenzi, Gad and Kanyabwisha, Faustin and Demarco, Maria and Muhoza, Benjamin and Hansen, Kristen and Mivumbi, Jean Paul and Murangwa, Anthere and Rurangwa, Theogene and Zawadi, Thierry Muvunyi and Kubwimana, Gallican and Gage, Julia C and Hébert, Tiffany and Adedimeji, Adebola and Nyirazinyoye, Laetitia and Yotebieng, Marcel and Mutesa, Leon and Anastos, Kathryn and Castle, Philip E},
title = {Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0333077}
}
EUVIMED